Izotropic Corporation (OTCMKTS:IZOZF – Get Free Report) was the recipient of a significant growth in short interest during the month of September. As of September 30th, there was short interest totaling 17,142 shares, a growth of 1,938.3% from the September 15th total of 841 shares. Based on an average daily volume of 38,591 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.0% of the company’s stock are short sold.
Izotropic Trading Down 0.3%
Shares of OTCMKTS:IZOZF traded down $0.00 during midday trading on Friday, reaching $0.12. 126,600 shares of the company’s stock traded hands, compared to its average volume of 16,900. Izotropic has a one year low of $0.10 and a one year high of $0.37. The stock has a 50 day moving average of $0.16 and a 200 day moving average of $0.18.
Izotropic (OTCMKTS:IZOZF – Get Free Report) last issued its earnings results on Monday, September 28th. The company reported ($0.01) earnings per share for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Sell-side analysts expect that Izotropic will post 0.03 earnings per share for the current year.
Izotropic Company Profile
Izotropic Corporation is a Canadian medical technology company focused on developing advanced breast-imaging solutions. The company’s principal product is the IzoView Breast CT Imaging System, a dedicated computed tomography platform designed to produce three-dimensional images of breast tissue.
IzoView is intended to support the detection, visualization and diagnosis of breast abnormalities by providing volumetric imaging rather than conventional two-dimensional views. The system is designed to image the breast without the compression used in traditional mammography, with the goal of improving the patient experience and helping clinicians evaluate complex breast tissue.
Izotropic is focused on the continued development, validation and potential commercialization of its technology for use in breast cancer screening and diagnostic imaging.
See Also
- Five stocks we like better than Izotropic
- 3 Unique ETFs With Strong Momentum for the End of the Year
- 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
- Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
- Delta Air Lines Faces a Fuel Crisis—But There’s a Silver Lining
Receive News & Ratings for Izotropic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Izotropic and related companies with MarketBeat.com's FREE daily email newsletter.
